Loncar Cancer Immunotherapy ETF (CNCR) Historical Stock Data

14.41 ↑0.46 (3.30%)
As of April 26, 2024, 1:04pm EST.

Historical Data

In the past 30 trading days, CNCR is down -0.72% a day on average. There have been 13 days where Loncar Cancer Immunotherapy ETF closed green and 17 days where CNCR closed red.

DateOpenCloseChangeLowHighVolume
2024-04-2514.2613.95↓$0.31 (-2.17%)13.8014.266.36K
2024-04-2414.5314.23↓$0.30 (-2.03%)14.2314.532.09K
2024-04-2314.4414.48↑$0.04 (0.28%)14.4414.652.45K
2024-04-2214.1414.21↑$0.07 (0.50%)14.0514.486.82K
2024-04-1914.3014.11↓$0.19 (-1.33%)13.9214.4614.95K
2024-04-1814.5814.36↓$0.22 (-1.51%)14.3614.631.76K
2024-04-1714.8914.57↓$0.32 (-2.15%)14.5714.89225.72K
2024-04-1614.9714.67↓$0.30 (-2.00%)14.6715.0030.02K
2024-04-1515.5915.01↓$0.58 (-3.72%)15.0015.5917.93K
2024-04-1215.9115.64↓$0.27 (-1.70%)15.3215.914.45K
2024-04-1115.7415.95↑$0.21 (1.31%)15.6716.004.86K
2024-04-1015.5315.55↑$0.02 (0.13%)15.4015.689.42K
2024-04-0915.7816.00↑$0.22 (1.39%)15.6916.0019.25K
2024-04-0815.7315.54↓$0.19 (-1.21%)15.4415.737.13K
2024-04-0515.4815.70↑$0.22 (1.42%)15.3715.754.68K
2024-04-0416.0315.53↓$0.50 (-3.12%)15.4716.065.50K
2024-04-0315.7415.87↑$0.13 (0.83%)15.5415.8710.80K
2024-04-0216.1715.73↓$0.44 (-2.72%)15.7316.177.84K
2024-04-0116.5516.29↓$0.26 (-1.57%)16.1116.5513.66K
2024-03-2816.4816.62↑$0.14 (0.85%)16.4816.7812.49K
2024-03-2715.9516.45↑$0.50 (3.13%)15.8416.4629.25K
2024-03-2615.9815.80↓$0.18 (-1.13%)15.7916.0840.50K
2024-03-2516.1615.89↓$0.27 (-1.67%)15.7516.3967.38K
2024-03-2216.3916.08↓$0.31 (-1.89%)16.0716.3936K
2024-03-2116.4416.47↑$0.03 (0.18%)16.3316.58154.71K
2024-03-2015.9516.20↑$0.25 (1.57%)15.8516.3261.22K
2024-03-1915.8115.91↑$0.10 (0.63%)15.7516.0924.44K
2024-03-1816.4115.99↓$0.42 (-2.56%)15.8116.4139.83K
2024-03-1516.0416.26↑$0.22 (1.37%)16.0416.35274.36K
2024-03-1416.5016.05↓$0.45 (-2.73%)15.8516.7169.17K
Create an account or log in to view more rows.

Discussions

Please log in or register to share your thoughts.

mezzymez2

$CNCR Guys when can we expect that 30% drop?

0 Like Report